Skip to main content
Courses_

Master of Science in Medicine (Pharmaceutical and Medical Device Development)

Fast track your career in medicine and health

About us

Global leaders in health education

  • No. 1 in Australia

    The University is ranked first in Australia and fourth in the world for graduate employability in the QS Graduate Employability Rankings 2017.

    Find out more.
  • Top ranked medical school

    Sydney Medical School is ranked first in Australia and 15th in the world in the QS World University Rankings by subject 2017.

    Find out more.

Overview

The Pharmaceutical & Medical Device Development program has been developed to meet the growing need for expertise in modern drug development practices and provide training in state-of-the-art techniques, approaches and requirements for the registration of medical products.

The program is tailored to professionals working in the pharmaceutical and bio-pharmaceutical industry, regulatory affairs, drug product evaluation, registration and therapeutic marketing sectors. It is designed to introduce students to modern approaches to drug and device design and development, providing an up-to-date set of skills essential for the current industry environment.

Students will learn current methods used in drug development, including:

  • molecular therapies 
  • novel-formulation
  • clinical trials design and analysis and 
  • personalised medicine. 

Pharmaco-economic, pharmaco-vigilance and pharmaco-epidemiology related to drug development will also be taught. The process of medicine and medical device registration encompassing therapeutic guidelines, regulation, documentation and post-registration follow up, and the range of drug technologies and medical devices that exist, their properties, classification, development and manufacturing requirements will be studied. Students will prepare and critically evaluate regulatory submissions, clinical trials and drug registration information.

The program is designed and delivered by leading industry and regulatory professionals and academics. For more information about the course please visit the Sydney Medical School web site.

Specialisations

There are no specialisations for this course.

Entry, fees, funding & how to apply

Depends on your qualification, citizenship status

The details on this page based on your selections are a guide only, and are subject to change.

Your fee

Your funding & scholarships

How to apply

What you'll study

The Masters requires the completion of 48 credit points of units of study including:

  • 12 credit points of compulsory units of study;
  • 24 credit points of stream specific units of study; and
  • 12 credit points of stream specific or general elective units of study.

All students in the Masters must complete compulsory units CEPI5100 Introduction to Clinical Epidemiology and the capstone unit PCOL5104 Pharm & Medical Device Development. Stream specific units must include PCOL5101 and PCOL5102.

If you are working full-time it is recommended you consider undertaking 1 or 2 units of study per semester. All core learning material is delivered online and some units have an intensive face-to-face teaching session.

Units of Study

Capstone experience

The capstone unit develops the critical thinking needed to transform a new therapeutic drug or device into a commercially viable product. 

Students will critically appraise scientific and clinical data and inforamation in order to prepare a final scientific dossier that would be suitable for submission to the TGA, EMA or FDA.

Students will work in groups to determine the review of the submission strategy and assign , individual work components where the each student develops solves a clinical/scienctific question related to one core aspect of this the process (i.e. a manufacturing, stability, clinical trial or other suitable component of the process) and. The group will meet at the face to face workshop to compile the dossier before presenting to their peers and industry experts a group project to prepare a final submission document.

Admission requirements

Admission to the Master of Science in Medicine requires:

  • successful completion of an embedded degree program (Graduate Certificate or Graduate Diploma); or 
  • a bachelor degree in a health or science-related discipline with honours or 12 months relevant work experience; or
  • a bachelor degree plus a postgraduate degree in a health or science-related discipline.
Future study options

Students who have completed the compulsory research unit and achieved an average of at least 75% in 24 credit points of compulsory and/or stream specific units of study will be eligible to apply for the Master of Science in Medicine (Advanced) (Pharmaceutical and Medical Device Development).

Graduate opportunities

The program has been designed to ensure that the knowledge you gain can be applied to current industry needs and be readily integrated into your day-to-day work.

You will have the opportunity to learn the basic science underpinning innovative therapies, current pharmaceutical trends, regulatory processes, communication and decision-making, and the evidence and ethics relevant to the pharmaceutical industry.

You will gain insights and understanding into the key steps involved in current pharmaceutical processes to bring products to market.

Domestic students

Indicative Postgraduate Student Contribution Amount


The student contribution amount for a Commonwealth Supported Place is an indication only of the amount payable in Year 1 for a standard full time load of 48 credit points (1.0 EFTSL). The exact student contribution that you pay will depend on the calendar year in which you undertake your study, and the specific units of study in which you ultimately enrol. For further information about how to calculate your specific total student contribution, please refer to the University's Tuition Fees website.

Annual review and fee increases


Importantly, student contribution amounts are subject to annual review by the University, and will increase each year of your period of study (subject to a Commonwealth specified cap), effective at the start of each calendar year.

Indicative Postgraduate Domestic Tuition Fee


The tuition fee for a domestic postgraduate student is an indication only of the fees payable in Year 1 for a standard full time load of 48 credit points (1.0 EFTSL). Depending on the calendar year in which you undertake your study, and if your study load is more or less than the 1.0 EFTSL, your tuition fee will differ from the indicative amount.

Annual review and fee increase


Importantly, tuition fees are subject to annual review by the University, and will increase each year of your period of study, effective at the start of each calendar year.

Additional incidental costs


For some courses there are incidental costs additional to the student contribution and/or course fee. Some of these incidental costs are significant, for example, course-specific materials, tools, protected clothing and equipment. Further information about these costs is available from https://sydney.edu.au/students/materials-and-equipment.html.

Credit card surcharge


Please note that a surcharge of 0.8% will apply for payments made by Visa, MasterCard or American Express. The surcharge is subject to review and may change. Information about payment methods and the surcharge is set out at: http://sydney.edu.au/study/finances-fees-costs/fees-and-loans/paying-your-fees.html.

Potential for inaccuracy


Whilst every reasonable effort has been made to include correct and up to date information here, you are also advised to consult directly with the Student Centre so that they can provide you with specific and up to date information about fees.

International students

Indicative International Tuition Fees for Postgraduate Students


The tuition fee for international postgraduate students is an indication only of the fees payable in Year 1 for a standard full time load of 48 credit points (1.0 EFTSL). Depending on the calendar year in which you undertake your study, and if your study load is more or less than the 1.0 EFTSL, your tuition fee will differ from the indicative amount.

Annual review and fee increases


Importantly, tuition fees are subject to annual review, and will increase each year of your period of study, effective at the start of each calendar year.

Additional incidental costs and health insurance


For some courses there are incidental costs additional to the tuition fees. Some of these incidental costs are significant, for example, course-specific materials, tools, protected clothing, and equipment. Further information about these costs is available from https://sydney.edu.au/students/materials-and-equipment.html. In addition to the fees indicated here for the course of study, International Students studying on an Australian Student Visa must have appropriate health insurance for the duration of their studies on a Student Visa through an approved provider of the Overseas Student Health Cover (OSHC) scheme. This is a requirement of the Australian Government, unless otherwise exempted by the Government.

Credit card surcharge


Please note that a surcharge of 0.8% will apply for payments made by Visa, MasterCard or American Express. The surcharge is subject to review and may change. Information about payment methods and the surcharge is set out at: http://sydney.edu.au/study/finances-fees-costs/fees-and-loans/paying-your-fees.html.

Potential for inaccuracy


Whilst every reasonable effort has been made to include correct and up to date information here, you are also advised to consult directly with the Student Centre so that they can provide you with specific and up to date information about fees.

To help you understand common terms that we use at the University, we offer an online glossary.